Scinai Immunotherapeutics Ltd.

SCNI

—

Advanced chart & tools →

Scinai Immunotherapeutics Ltd.SCNI

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.00

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$1.31M

Net income

$-8.31M

Net margin

-633.6%

Gross margin

-202.3%

Dividends & financials

Scinai Immunotherapeutics Ltd. (SCNI) reported revenue of $1.31M and net income of $-8.31M, or $-0.00 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.